Cohen et al. [73] extended these findings in a 14-country trial of 564 patients, administering single doses of 3 mg/kg or 15 mg/kg murine anti–TNF-α mAb within 16 h of sepsis onset. This evidence concerns the gene TNF and Sepsis.